Emgality 300 mg: First and only calcitonin gene-related peptide (CGRP) antibody proven to treat patients with episodic cluster headache1,2
For your patients with episodic cluster headache,

aHypothetical patient profile.
Emgality 300 mg: Life with fewer episodic cluster headache attacks is possible for patients like Frank1
- 1 to 4 cluster attacks per day during active periods that last 7 weeks, followed by periods (≥3 months) of remission
Get your eligible patients started. Download savings cardsc.
cGovernmental beneficiaries excluded; terms and conditions apply.
References: 1. Emgality [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. 2. Data on File. Lilly USA, LLC. DOF-GZ-US-0085. 3. Data on File. Lilly USA, LLC. DOF-GZ-US-0120. 4. Data on File. Lilly USA, LLC. DOF-GZ-US-0093.